Anthony El-Khoueiry, MD, USC Norris Comprehensive Cancer Center

home / authors / anthony-el-khoueiry-md-university-of-southern-california-norris-comprehensive-cancer-center

Articles

Shanita Hughes-Halbert, PhD

Drs El-Khoueiry and Hughes-Halbert on the Importance of a Multidisciplinary Approach in Cancer Care

March 17th 2023

Anthony B. El-Khoueiry, MD, and Chanita Hughes-Halbert, PhD, discuss their role within the Stand Up To Cancer® 4-team initiative, focusing on diversity in early-phase clinical trials.

Read More

Dr. El-Khoueiry on the Frontline Treatment Landscape in HCC

Dr. El-Khoueiry on the Frontline Treatment Landscape in HCC

August 17th 2020

Anthony B. El-Khoueiry, MD, discusses the frontline treatment landscape of hepatocellular carcinoma.

Read More

HCC: Applying Recent Data Into Practice

HCC: Applying Recent Data Into Practice

July 13th 2020

Read More

HCC: Emerging Therapies Under Investigation

HCC: Emerging Therapies Under Investigation

July 13th 2020

Read More

Combination Regimens for HCC Treatment

Combination Regimens for HCC Treatment

July 13th 2020

Read More

Emerging Biomarkers in Hepatocellular Carcinoma

Emerging Biomarkers in Hepatocellular Carcinoma

July 13th 2020

Read More

HCC: Liver Function and Treatment Decisions

HCC: Liver Function and Treatment Decisions

July 13th 2020

Read More

Safety Profiles of Novel Therapies for HCC

Safety Profiles of Novel Therapies for HCC

July 13th 2020

Read More

Sequencing of Novel Therapies in HCC

Sequencing of Novel Therapies in HCC

July 13th 2020

Read More

Regorafenib or Cabozantinib for Second-Line HCC

Regorafenib or Cabozantinib for Second-Line HCC

July 13th 2020

Read More

Selecting Second-Line Therapy for HCC

Selecting Second-Line Therapy for HCC

July 13th 2020

Read More

Second-Line Treatment for Hepatocellular Carcinoma

Second-Line Treatment for Hepatocellular Carcinoma

July 13th 2020

Read More

Novel Combinations to Treat HCC

Novel Combinations to Treat HCC

July 13th 2020

Read More

Immunotherapy in Liver Cancer

Immunotherapy in Liver Cancer

July 13th 2020

Read More

HCC: Treating Patients With Atezolizumab/Bevacizumab

HCC: Treating Patients With Atezolizumab/Bevacizumab

July 13th 2020

Read More

IO and VEGF Inhibition in Hepatocellular Carcinoma

IO and VEGF Inhibition in Hepatocellular Carcinoma

July 13th 2020

Read More

Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma

Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma

July 13th 2020

Read More

Locoregional and Systemic Therapy for HCC

Locoregional and Systemic Therapy for HCC

July 13th 2020

Read More

Hepatocellular Carcinoma: Diagnostic Work-Up

Hepatocellular Carcinoma: Diagnostic Work-Up

July 13th 2020

Read More

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma

July 13th 2020

Read More

Incidence of Liver Cancer in the US

Incidence of Liver Cancer in the US

July 13th 2020

Read More